TRAF6调控的代谢重编程促进白血病进展
该研究探讨TRAF6在急性髓系白血病(AML)发病中的作用,发现AML细胞中TRAF6缺失在体外和体内显著损害白血病功能,并诱导糖酵解、TCA循环和核酸代谢改变及线粒体膜电位和呼吸能力受损。TRAF6表达与OGT表达正相关,强制表达OGT或药理抑制OGA可恢复TRAF6缺失白血病细胞的生长能力和代谢活性,提示TRAF6/OGT/O-GlcNAc轴是白血病发生中代谢重编程的潜在调控者。
要点
- AML细胞中TRAF6缺失在体外和体内显著损害白血病功能。
- TRAF6缺失诱导糖酵解、TCA循环和核酸代谢改变及线粒体膜电位和呼吸能力受损。
- 强制表达OGT或药理抑制OGA可恢复TRAF6缺失白血病细胞的生长能力和代谢活性。
核心结论
- TRAF6在白血病中具有致癌功能,TRAF6/OGT/O-GlcNAc轴是白血病发生中代谢重编程的潜在调控者。
研究设计与样本
- 研究在AML细胞中探讨TRAF6缺失的体外和体内白血病功能及代谢改变。
主要发现
- AML细胞中TRAF6缺失在体外和体内显著损害白血病功能。
- TRAF6缺失诱导糖酵解、TCA循环和核酸代谢改变以及线粒体膜电位和呼吸能力受损。
- 白血病细胞中TRAF6表达与OGT表达呈正相关。
- 强制表达OGT或药理抑制OGA可恢复TRAF6缺失白血病细胞的生长能力和代谢活性。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
TNF receptor associated factor 6 (TRAF6) is an E3 ubiquitin ligase that has been implicated in myeloid malignancies. Although altered TRAF6 expression is observed in human acute myeloid leukemia (AML), its role in the AML pathogenesis remains elusive. In this study, we showed that the loss of TRAF6 in AML cells significantly impairs leukemic function in vitro and in vivo, indicating its functional importance in AML subsets. Loss of TRAF6 induces metabolic alterations, such as changes in glycolysis, TCA cycle, and nucleic acid metabolism as well as impaired mitochondrial membrane potential and respiratory capacity. In leukemic cells, TRAF6 expression shows a positive correlation with the expression of O-linked N-acetylglucosamine (O-GlcNAc) transferase (OGT), which catalyzes the addition of O-GlcNAc to target proteins involved in metabolic regulation. The restoration of growth capacity and metabolic activity in leukemic cells with TRAF6 loss, achieved through either forced expression of OGT or pharmacological inhibition of O-GlcNAcase (OGA) that removes O-GlcNAc, indicates the significant role of O-GlcNAc modification in the TRAF6-related cellular and metabolic dynamics. Our findings highlight the oncogenic function of TRAF6 in leukemia and illuminate the novel TRAF6/OGT/O-GlcNAc axis as a potential regulator of metabolic reprogramming in leukemogenesis.
引用
- Matsui S, Ri C, Bolanos LC, et al. Metabolic reprogramming regulated by TRAF6 contributes to the leukemia progression. Leukemia. 2024. PMID: 38609495. doi:10.1038/s41375-024-02245-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。